EMR:NYSE

Emerson Electric (EMR) is trading at $141.12, comfortably above its 200‑day SMA of $136.32 but below the 20‑day ($149.16) and 50‑day ($147.05) averages, indicating a short‑term pullback within a longer‑term uptrend. The RSI at 42 suggests neutral momentum, while the MACD histogram remains deeply negative, a bearish signal reinforced by decreasing volume and a 30‑day volatility of over 40%, pointing to heightened price swings. Fundamentals show a trailing P/E of 34.6 versus an industry average of 29.5, and a DCF fair value near $62.65, implying the stock is currently overvalued despite solid earnings growth (forward EPS of $7.18 versus $4.08 trailing) and a forward P/E of 19.6. The dividend yield of 1.6% is supported by a payout ratio just above 50% and healthy free cash flow, suggesting sustainability. Recent news highlights a Q1 earnings beat with 9% order growth, a strategic push into AI‑driven water automation, and a downgrade from Deutsche Bank to “Hold,” tempering enthusiasm. Overall, EMR balances strong long‑term growth catalysts against short‑term technical weakness and valuation pressure.